B8F — Biofrontera AG Balance Sheet
0.000.00%
Last trade - 00:00
- €19.91m
- €17.69m
- €25.74m
- 35
- 68
- 13
- 30
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 20.2 | 12.2 | 17.1 | 6.96 | 7.25 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3.45 | 5.04 | 3.51 | 1.52 | 2.22 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 27.6 | 22.5 | 26.1 | 14.4 | 15.1 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.794 | 5.23 | 5.05 | 2.28 | 3.01 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 39.1 | 58.4 | 56.4 | 76.7 | 32.7 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7.77 | 11.6 | 8.29 | 17.5 | 8.39 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 22.8 | 48.4 | 49 | 18.7 | 12.4 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 16.4 | 9.96 | 7.38 | 58 | 20.3 |
Total Liabilities & Shareholders' Equity | 39.1 | 58.4 | 56.4 | 76.7 | 32.7 |
Total Common Shares Outstanding |